Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


PDA offers support as Lloydspharmacy branch sale rumours persist

Pharmacists working at Lloydspharmacy have been reassured by the Pharmacists’ Defence Association (PDA) following speculation that the multiple plans to divest itself of “a number” of branches. 

In a statement, the PDA claimed it had been made aware that “a number of Lloydspharmacy” branches are “currently going through the divestiture process”.

The union said it understands that “such changes of ownership will be of significant concern to individuals who are employed at the pharmacies”.

Lloydspharmacy has not explicitly confirmed whether its is divesting any branches, or how many branches are affected if this is indeed the case.

However, the PDA reassured members that where an existing business is acquired and absorbed into another, existing employees “should not see any major changes to their working arrangements because of the transfer”.

If members are concerned, they should contact the PDA service centre “in the first instance”, it added.

Read more: Lloydspharmacy may sell substantial number of branches, sources tell C+D

“It is better to contact us as questions or concerns emerge, rather than allow the situation to develop before confirming and exercising your rights at work,” the union said.

It comes after several sources told C+D in May of the multiple’s alleged plans to sell a substantial number of branches. At the time, Lloydspharmacy said “no decisions” had been made.

Lloydspharmacy: Patient safety is “top priority”


A spokesperson for Lloydspharmacy told C+D yesterday (November 22) that the multiple “regularly reviews its pharmacy estate to ensure it is operating sustainably”. 

“Any decision to sell stores is taken in the interests of patients, colleagues and the business,” they added.

Patient safety “remains our top priority, ensuring our customers and patients are always able to access vital prescriptions, health advice, products and services”, they added.

Read more: McKesson completes sale of Lloydspharmacy to Aurelius Group

In April, private equity firm Aurelius Group completed a £477 million acquisition of McKesson UK, Lloydspharmacy’s parent company.

The group rebranded McKesson UK to Hallo Healthcare in September.

Lloydspharmacy revealed in its financial report for 2020/2021 that it had decided to close, merge, or sell 76 branches in 2020/21 as part of a “rationalisation programme” it started as a consequence of the “challenging” government funding model.


Related Content


Pharmacy Manager

Apply Now
Latest News & Analysis
See All



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts